Islet cell autoantibody levels after the diagnosis of young adult diabetic patients.

@article{Jensen2007IsletCA,
  title={Islet cell autoantibody levels after the diagnosis of young adult diabetic patients.},
  author={Richard A. Jensen and Lisa K. Gilliam and Carina Torn and Mona Landin-Olsson and Jerry Palmer and Karolina {\AA}kesson and Ingrid Kockum and Barbro Lernmark and Anders F Karlsson and Kristian Francis Lynch and Norman Breslow and {\AA}ke Lernmark and G{\"o}ran Sundkvist},
  journal={Diabetic medicine : a journal of the British Diabetic Association},
  year={2007},
  volume={24 11},
  pages={1221-8}
}
AIMS The aim was to determine the course of islet cell antibodies [glutamate decarboxylase (GADA), tyrosine phosphatase-like islet antigen 2 (IA-2A) and islet cell (ICA)] after the diagnosis of the diabetic patient. METHODS The Diabetes Incidence Study in Sweden (DISS) attempted to prospectively enrol all newly diagnosed diabetic patients aged 15-34 years during 1992 and 1993. C-peptide and autoantibody levels were determined from venous blood samples at diagnosis and again at yearly… CONTINUE READING